Innoscience has announced that the Munich Regional Court has issued two rulings confirming that its currently marketed GaN power devices do not fall within the scope of the German patents asserted by Infineon. As a result, Innoscience is free to continue selling and distributing these products in Germany without any restrictions.
The court’s decision aligns with a recent final ruling by the U.S. International Trade Commission (ITC), which concluded that Innoscience’s current products do not infringe Infineon’s U.S. patent covering packaging design (U.S. Patent No. 9,899,481). The German case involved corresponding patents from the same patent family.
While the Munich Court identified infringement involving a small number of older packaged 650–700V transistor products, those devices had already been phased out and are no longer part of Innoscience’s active portfolio. Consequently, any injunction would apply only to these discontinued products and would not affect the company’s current offerings. Innoscience stated that the ruling has no impact on its business activities in Germany or on customers using its products.
The decisions mark another significant milestone in Innoscience’s string of favorable outcomes across major jurisdictions. They follow the company’s recent success in China, where it secured an injunction and damages award against Infineon, as well as its decisive victory at the ITC in the United States last month. Together, these rulings reaffirm the legality of Innoscience’s current product portfolio and its ability to operate freely in key global markets.
While proceedings in Germany remain ongoing, including Innoscience’s invalidity challenges to the asserted German patent, the growing body of decisions across China, the United States, and Germany underscores that the global litigation campaign initiated by Infineon has not altered the competitive position of Innoscience’s core products. To the contrary, independent judicial findings across multiple jurisdictions have consistently validated the robustness of Innoscience’s technology and reinforced market confidence in the company’s product compliance and innovation capabilities.
Innoscience remains committed to advancing its technology leadership and expanding its global footprint, delivering cutting-edge GaN solutions to customers worldwide in a fair and competitive marketplace.
